Skip to main content
Contact Us
Sign Up
Subscriber Sign In
English
日本語
navigation
Search
What We Do
Vantage
News
Analysis
Policy & Pricing
Data Insights
Events
Medtech
Therapy Areas
About Vantage
Editorial team
Products & Services
Consensus Forecasts
Pharma
EvaluatePharma
EvaluatePharma Vision
Custom Solutions
How We Can Help You
Pharma and Biotech
Medtech
Financial Services
Management Consultancies
Service Providers
Client Success
Customer Testimonials
Thought Leadership
About Us
Media Centre
Press Releases
Media Coverage
Executive Team
Vision & History
Careers
Current Vacancies
Contact Us
Sign Up for Vantage
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Policy & Pricing
Policy & Regulation
Pricing
Data Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
Primary tabs
View
(active tab)
Sanofi Pasteur MSD
June 15, 2018
Snippet roundup: Panel says no to BTG and Sirtex says no to Varian
May 22, 2017
Astrazeneca's dealing cannot mask its problems
September 18, 2014
CureVac emerges with €35m cancer vaccine endorsement
July 29, 2014
KaloBios's stumbles provide a lesson to enthusiastic IPO investors
April 22, 2014
How oncology, vaccines and OTC will look after pharma’s game of musical chairs
November 05, 2013
Merck’s Gardasil follow-on succeeds but cost questions remain
September 19, 2013
EP Vantage interview – Major vaccines player takes a leaf out of pharma’s book
June 21, 2013
Event – Merck gears up for Gardasil successor
September 30, 2011
Merck's improved Gardasil could cause a stir
March 30, 2010
Product sales in 2009: hits and misses
September 10, 2009
Glaxo's US Cervarix approval more important for pride than sales
Load More
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
July 31, 2019
Vantage Pharma, Biotech & Medtech Half-Year Review 2019
February 26, 2019
Vantage Pharma, Biotech and Medtech 2018 in Review
Editor's Picks
September 05, 2019
Esmo 2019 preview – Parps on parade
September 10, 2019
Alzheimer's setbacks have prompted $39bn of market cap losses this year
September 12, 2019
Should the diabetes development road end for Sanofi?
August 27, 2019
Six burning Otezla questions
August 29, 2019
The PCSK9 wars continue, but at what cost?
